Doximity, Inc. (DOCS) vs DENTSPLY SIRONA Inc. (XRAY)

A side-by-side comparison of Doximity, Inc. and DENTSPLY SIRONA Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 26, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnDOCS vs XRAY

growth of $100 · dividends reinvested · last 5y
DOCS -53.3% (-14.1%/yr)XRAY -81.4% (-28.5%/yr)DOCS compounded faster over this window
50100150200Start $10020222023202420252026$47$19
DOCS XRAY

DOCS vs XRAY: by the numbers

  • DOCS is the larger company ($4.63B vs $2.19B market cap).
  • DOCS is profitable (25.48% net margin) while XRAY runs a net loss (-14.99%).
  • DOCS grew revenue faster over the past five years (21.94% vs 1.96% CAGR).
  • XRAY pays a dividend (2.92% yield), while DOCS has no payments in the available dividend history.

Metrics side by side

Valuation

MetricDOCSXRAY
P/E ratio29.11N/A
Forward P/E16.007.17
P/S ratio7.210.60
P/B ratio5.161.63
EV / EBITDA21.105.00
FCF yield6.33%6.50%

Profitability

MetricDOCSXRAY
Gross margin88.07%49.52%
Operating margin29.60%11.69%
Net margin25.48%-14.99%
ROE18.24%-40.41%
ROIC15.35%10.03%

Dividends

MetricDOCSXRAY
Dividend yieldN/A2.92%

Growth (annualized)

MetricDOCSXRAY
Revenue CAGR (5Y)21.94%1.96%
EPS CAGR (5Y)54.32%-0.93%
FCF CAGR (5Y)23.75%-25.74%
Total return CAGR (5Y)-23.11%-27.44%

Frequently asked

Which has grown faster, DOCS or XRAY?
Over the past five years, DOCS grew revenue faster — DOCS at a 21.94% CAGR versus XRAY at 1.96%.
Does DOCS or XRAY pay a bigger dividend?
XRAY pays a dividend (2.92% yield), while DOCS has no payments in the available dividend history.
Is DOCS or XRAY more profitable?
DOCS runs the higher net margin — DOCS at 25.48% versus XRAY at -14.99%.
How have DOCS and XRAY total returns compared?
Over the past 5 years, DOCS delivered -23.11% and XRAY delivered -14.53% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 26, 2026.